Corrigan Catherine 4

What Happened

• Catherine Corrigan, President & CEO and a director of Exponent, exercised stock options on Feb 17, 2026 and immediately sold a portion of the resulting shares. She exercised options to acquire 3,226 shares at $25.41 (cost $81,957) and 2,380 shares at $29.05 (cost $69,139), for a total of 5,606 shares acquired through option exercises. She sold 2,218 shares at $67.16 (proceeds $148,971) and 1,702 shares at $67.14 (proceeds $114,269), totaling 3,920 shares sold for about $263,240.
• The filing shows corresponding derivative-line entries (marked “disposed” for the options) that reflect conversion of the option instruments into common stock as part of the exercise.

Key Details

• Transaction date: 2026-02-17; Filing date: 2026-02-18 (timely).
• Exercise details: 3,226 shares @ $25.41 ($81,957) and 2,380 shares @ $29.05 ($69,139).
• Sales (open market): 2,218 shares @ $67.16 ($148,971) and 1,702 shares @ $67.14 ($114,269) — total proceeds ≈ $263,240.
• Shares owned after the transaction: not disclosed in the Form 4.
• Footnotes: F1 — sales were to cover the option exercise price and taxes; F2 — the stock option vests in four equal annual installments; F3 — not applicable.
• No 10b5-1 plan or late filing indicated.

Context

• This pattern (exercise combined with immediate sale of some shares to cover costs and tax withholding) is a common way executives realize shares from options without injecting cash; per the filing, the sales were to cover exercise price and taxes, effectively a cashless transaction for the exercised options.
• These transactions are routine for option exercises and do not, by themselves, indicate the insider’s view on long-term company prospects.